Imipramine Exploits Histone Deacetylase 11 To Increase the IL-12/IL-10 Ratio in Macrophages Infected with Antimony-Resistant Leishmania donovani and Clears Organ Parasites in Experimental Infection

被引:34
作者
Mukherjee, Sandip [1 ]
Mukherjee, Budhaditya [1 ]
Mukhopadhyay, Rupkatha [1 ]
Naskar, Kshudiram [1 ]
Sundar, Shyam [2 ]
Dujardin, Jean-Claude [3 ]
Roy, Syamal [1 ]
机构
[1] CSIR, Indian Inst Chem Biol, Dept Infect Dis & Immunol, Kolkata 700032, India
[2] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India
[3] Inst Trop Med, B-2000 Antwerp, Belgium
关键词
VISCERAL LEISHMANIASIS; NITRIC-OXIDE; KALA-AZAR; INTERLEUKIN-10; IL-10; DRUG-RESISTANCE; MILTEFOSINE; GENERATION; EXPRESSION; RESPONSES; FAILURE;
D O I
10.4049/jimmunol.1400710
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The efflux of antimony through multidrug resistance protein (MDR)-1 is the key factor in the failure of metalloid treatment in kalaazar patients infected with antimony-resistant Leishmania donovani ((SbLD)-L-R). Previously we showed that MDR-1 upregulation in (SbLD)-L-R infection is IL-10-dependent. Imipramine, a drug in use for the treatment of depression and nocturnal enuresis in children, inhibits IL-10 production from (SbLD)-L-R-infected macrophages ((SbLD)-L-R-M phi s) and favors accumulation of surrogates of antimonials. It inhibits IL-10-driven nuclear translocation of c-Fos/c-Jun, critical for enhanced MDR-1 expression. The drug upregulates histone deacetylase 11, which inhibits acetylation of IL-10 promoter, leading to a decrease in IL-10 production from (SbLD)-L-R-M phi s. It abrogates (SbLD)-L-R-mediated p50/c-Rel binding to IL-10 promoter and preferentially recruits p65/RelB to IL-12 p35 and p40 promoters, causing a decrease in IL-10 and overproduction of IL-12 in (SbLD)-L-R-M phi s. Histone deacetylase 11 per se does not influence IL-12 promoter activity. Instead, a imipramine-mediated decreased IL-10 level allows optimal IL-12 production in (SbLD)-L-R-M phi s. Furthermore, exogenous rIL-12 inhibits intracellular (SbLD)-L-R replication, which can be mimicked by the presence of Ab to IL-10. This observation indicated that reciprocity exists between IL-10 and IL-12 and that imipramine tips the balance toward an increased IL-12/IL-10 ratio in (SbLD)-L-R-M phi s. Oral treatment of infected BALB/c mice with imipramine in combination with sodium stibogluconate cleared organ (SbLD)-L-R parasites and caused an expansion of the antileishmanial T cell repertoire where sodium stibogluconate alone had no effect. Our study deciphers a detailed molecular mechanism of imipramine-mediated regulation of IL-10/IL-12 reciprocity and its impact on (SbLD)-L-R clearance from infected hosts.
引用
收藏
页码:4083 / 4094
页数:12
相关论文
共 57 条
  • [1] Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis
    Bacellar, O
    Brodskyn, C
    Guerreiro, J
    BarralNetto, M
    Costa, CH
    Coffman, RL
    Johnson, WD
    Carvalho, EM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) : 1515 - 1518
  • [2] Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection
    Basu, Jayati Mookerjee
    Mookerjee, Ananda
    Banerjee, Rajdeep
    Saha, Manik
    Singh, Subhankar
    Naskar, Ksudiram
    Tripathy, Gayetri
    Sinha, Prabhat K.
    Pandey, Krishna
    Sundar, Shyam
    Bimal, Sanjeev
    Das, Pradip K.
    Choudhuri, Sournitra K.
    Roy, Syarnal
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) : 1080 - 1093
  • [3] Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1768-1797.2006, 10.1128/AAC.50.5.1788-1797.2006]
  • [4] Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation:: Evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis
    Basu, R
    Bhaumik, S
    Basu, JM
    Naskar, K
    De, T
    Roy, S
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (11) : 7160 - 7171
  • [5] HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages
    Basu, Rajatava
    Roy, Syamal
    Walden, Peter
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (09) : 1373 - 1380
  • [6] The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure
    Belkaid, Y
    Hoffmann, KF
    Mendez, S
    Kamhawi, S
    Udey, MC
    Wynn, TA
    Sacks, DL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) : 1497 - 1506
  • [7] Brun R, 2011, FUTURE MICROBIOL, V6, P677, DOI [10.2217/fmb.11.44, 10.2217/FMB.11.44]
  • [8] Drug Resistance in Leishmaniasis
    Chakravarty, Jaya
    Sundar, Shyam
    [J]. JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2010, 2 (02) : 167 - 176
  • [9] Repression of IP-10 by Interactions between Histone Deacetylation and Hypermethylation in Idiopathic Pulmonary Fibrosis
    Coward, William R.
    Watts, Keira
    Feghali-Bostwick, Carol A.
    Jenkins, Gisli
    Pang, Linhua
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (12) : 2874 - 2886
  • [10] Short Report: Development of Post-Kala-Azar Dermal Leishmaniasis (PKDL) Miltefosine-Treated Visceral Leishmaniasis
    Das, Vidya Nand Rabi
    Pandey, Krishna
    Verma, Neena
    Lal, Chandra Shekhar
    Bimal, Sanjeev
    Topno, Roshan Kamal
    Singh, Dharmendra
    Siddiqui, Niyamat Ali
    Verma, Rakesh Bihari
    Das, Pradeep
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 80 (03) : 336 - 338